Clinical research examining the role of hematopoietic stem cell transplantation (SCT) in the
therapy of myelodysplastic syndromes (MDS) in adults is presented and critically evaluated …

Allogeneic hematopoietic SCT (allo-HCT) is the only curative therapy for myelodysplastic
syndrome (MDS). Numerous myeloablative (MA), nonmyeloablative SCT (NST) and reduced …

BACKGROUND. Conventional karyotype has an established role in myelodysplastic
syndrome (MDS) and is included in the International Prognostic Scoring System (IPSS) for …

Hematopoietic stem cell transplantation (HSCT) is a well‐established method for a variety of
acquired and congenital diseases. However, the limited number and sources of therapeutic …

Abstract In the FAB (French–American–British) and WHO (World Heath Organization)
classifications, the blasts in erythroleukemia (M6a) are enumerated from the marrow …

Expression of CD34 on mature-appearing megakaryocytes can been seen in various
intrinsic bone marrow (BM) disorders as well as reactive bone marrows. In this study we …

Although it is only used to treat a minority of patients with myelodysplastic syndromes, stem
cell transplantation (SCT) is the only proven curative treatment for this condition. Because …

The only way to cure leukemia is by cooperative research. To optimize research, the
European LeukemiaNet integrates 105 national leukemia trial groups and networks, 105 …

Autologous hematopoietic stem cell transplantation (HSCT) has a long tradition in Europe.
Initially developed as a tool to restore rapid remission or chronic phase in patients with …

Therapeutic decisions in patients with myelodysplastic syndromes (MDS) are very complex.
The dilemma that confronts the management of MDS is illustrated by the presence of only …